Global pharmaceutical market
U.S. sales will represent 56% of global Rx market in 2000, according to data in PhRMA's Pharmaceutical Industry Profile 2000. PhRMA estimates that domestic sales will increase 15% to $105.6 bil. in 2000. For the first time, the association has gathered sales projections for non-U.S. companies, and projects total pharmaceutical sales outside the U.S. of $83.2 bil. in 2000, for a global market of $188.8 bil
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth